Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Small Cell Lung Carcinoma × Tiragolumab × Clear all

Phase

Status

Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 7 Squamous Cell Carcinoma of Head and Neck 2 Esophageal Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Pancreatic Adenocarcinoma 1 PD-L1-selected Solid Tumors 1 Neoplasm Metastasis 1 Melanoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Hepatocellular 1

Interventions

Carboplatin 45 Etoposide 42 Cisplatin 40 Topotecan 36 Irinotecan 20 Paclitaxel 15 Gemcitabine 13 Nivolumab 12 pembrolizumab 11 Ipilimumab 10 atezolizumab 9 durvalumab 8 Radiotherapy 8 Bevacizumab 7 rovalpituzumab tesirine 6 amrubicin 6 Doxorubicin 6 Docetaxel 6 Counseling 6 trilaciclib 5 Sunitinib 5 Psychiatric Rehabilitation 5 Platinum 5 Imatinib Mesylate 5 Bortezomib 5 tremelimumab 4 olaparib 4 etoposide phosphate 4 PM 01183 4 Early Intervention, Educational 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04256421 2026-01-28

SKYSCRAPER-02

Hoffmann-La Roche

Phase 3 Completed

490 enrolled 31 charts

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡